A revision of an "excitotoxic hypothesis" of schizophrenia is summarized. T
he hypothesis suggests that in, at least, a subtype of patients with schizo
phrenia, progressive excitotoxic neuronal cell death in hippocampal and cor
tical areas occurs via "disinhibition" of glutamatergic projections to thes
e areas. Patients who have excitotoxic damage would be expected to have poo
r outcomes characterized, perhaps, by anatomic evidence of progressive neur
odegeneration, pronounced negative symptoms and cognitive deficits, and pro
found psychosocial deterioration. Disinhibited glutamatergic activity could
result from inhibition of N-methyl-D-aspartate (NMDA) receptor-mediated ne
urotransmission and a consequent failure to stimulate inhibitory gamma-amin
obutyric acid(GABA) ergic interneurons, and/or anatomic degeneration of inh
ibitory GABAergic interneurons. The result of these hypothesized mechanisms
is excessive stimulation of the alpha-amino-3-hydroxy-5-methylisoxazole-4-
propionic acid (AMPA)/kainate class of glutamate receptor complexes. In tur
n, this excessive stimulation of AMPA/kainate receptors could lead to disru
ption of ionic gradients, depletion of energy reserves expended in an attem
pt to restore and maintain the ionic disequilibrium across neuronal membran
es, generation of reactive oxygen species, and cell death from apoptotic an
d other mechanisms. The postulated existence of disinhibited glutamatergic
neurotransmission and the subsequent cascade of excitotoxic events resultin
g from NMDA receptor hypofunction (NRH), anatomic degeneration of inhibitor
y GABAergic interneurons, or a combination of the two has suggested a diver
se variety of experimental therapeutic interventions For schizophrenia. The
se interventions include facilitation of NMDA receptor-mediated neurotransm
ission, potentiation of GABAergic neurotransmission, antagonism of AMPA/kai
nate receptors, and "quenching" of locally generated reactive oxygen specie
s. In fact, several of these approaches have already been pursued or are pr
oposed as part of a systematic clinical investigation of the revised excito
toxic hypothesis of schizophrenia.